TCL Archive In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm January 23, 1998
TCL Archive In Brief: Robert Weinberg to Receive Bristol-Myers Award; Leffall Chosen for Poster Series April 13, 1984
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005